June 14, 2022
  • MOASC Co-Founder, past President, past Board Chair and Board Member, Cary Presant, M.D., recommends 5 tests for every man under age 55.
  •  Dr. Presant shares his synopsis of ASCO 2022 Chicago.
  • As a MOASC Member, don't miss out on saving an average of $4,350! PayGround's offer for MOASC members ends June 30, 2022. 
Programs
  • Cytopenic Myelofibrosis (MF) and VONJO™ (Pacritinib) Overview, Clinical Webinar, Thursday, June 16, 2022, 5:30pm-PDT.
  • CAR T-cell therapy for the Treatment of Relapsed/Refractory Large B-cell Lymphoma clinical webinar, June 21, 2022 5:30pm.
  • Spotlight On Clinical Oncology, Saturday, August 27, 2022,1:00pm to 7:00pm-PDT. This Activity is approved for AMA PRA Category 1 Credits™
  • TODAY! Melanoma Patient Symposium, “New Developments in Melanoma 2022,” Webinar, Tuesday, June 14, 4:30pm-6:15pm.
California
  • California lawmakers passed a $300 billion+ budget bill yesterday. 
  • CMA endorses AMA principles for sustainable Medicare payment reform.
Medicare
  • Key Takeaways from the FY 2023 Medicare Hospital Inpatient Prospective Payment System (IPPS) Proposed Rule Comments due June 17, 2022 by 2:00 p.m. PDT
  • Radiation oncologists support CMS' indefinite delay of episodic payments for radiation treatment.
National
  • The Federal Trade Commission (FTC) has unanimously voted to study the pharmacy benefit managers, sending subpoenas for information to many PBMs.
  • Weekly electronic symptom-tracking surveys improved cancer patients’ physical function, symptom control and health-related quality of life.
  • Using evidence-based guidelines may decrease total cost of cancer care. 
  • How to correctly document and bill for patient e-visits.
‌
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.